Recommendations against the use of betacarotene supplements for the prevention of cardiovascular disease or cancer have been published by the US Preventive Services Task Force
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.431, 2003-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
US Task Force advises against use of HRT
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 386, 2002-01 ,pp. :